FDX
44
-7
WYNN
30
2
LOW
58
2
KLAC
47
-3
FLR
45
-3
PPL
59
2
NOC
56
2
CF
53
5
ZION
71
3
SEE
53
3
DGX
48
-2
VRTX
62
-6
GM
72
3
ALLE
53
-4
A
40
-3
MSFT
51
-4
RL
78
-5
JNJ
39
-2
AN
54
2
MMC
61
-3
FDX
44
-7
WYNN
30
2
LOW
58
2
KLAC
47
-3
FLR
45
-3
PPL
59
2
NOC
56
2
CF
53
5
ZION
71
3
SEE
53
3
DGX
48
-2
VRTX
62
-6
GM
72
3
ALLE
53
-4
A
40
-3
MSFT
51
-4
RL
78
-5
JNJ
39
-2
AN
54
2
MMC
61
-3
Financhill
Back

Bolt Biotherapeutics Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
40

BOLT
Bolt Biotherapeutics

Last Price:
0.64
Seasonality Move:
-18.53%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Bolt Biotherapeutics Price Quote

$0.64
+0.00 (+0.63%)
(Updated: November 12, 2024 at 5:55 PM ET)

Bolt Biotherapeutics Key Stats

Sell
40
Bolt Biotherapeutics (BOLT) is a Sell
Day range:
$0.63 - $0.66
52-week range:
$0.55 - $1.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.16
P/B ratio:
0.28%
Volume:
25.5K
Avg. volume:
108.3K
1-year change:
-34.43%
Market cap:
$24.3M
Revenue:
$7.9M
EPS:
$-1.74

How Much Does Bolt Biotherapeutics Make?

Is Bolt Biotherapeutics Growing As A Company?

  • What Is Bolt Biotherapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.11%
  • What Is Bolt Biotherapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Bolt Biotherapeutics Stock Price Performance

What Is Bolt Biotherapeutics 52-Week High & Low?

Bolt Biotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bolt Biotherapeutics?

Is Bolt Biotherapeutics Cash Flow Positive?

  • What Is BOLT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$63.9M
  • What Is Bolt Biotherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Bolt Biotherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $56.7M

Bolt Biotherapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BOLT return on invested capital is -57.72%
  • What Is Bolt Biotherapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -41.72%
  • What Is BOLT Return On Equity?
    ROE is a measure of profitability and is -57.72%

Bolt Biotherapeutics Earnings Date & Stock Price

Bolt Biotherapeutics Competitors

  • Who Are Bolt Biotherapeutics's Competitors?
    Below is a list of companies who compete with Bolt Biotherapeutics or are related in some way:
    • iBio Inc (IBIO)
    • SeaStar Medical Holding Corp (ICU)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Bolt Biotherapeutics Dividend Yield

Bolt Biotherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 4.55%
Revenue: -11.03% 43.02%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 1.75
Upside from Last Price: 175.16%

Major Shareholders

  • How many BOLT shares are owned by institutional investors?
    28.2M BOLT shares are owned by institutional investors
  • How many BOLT shares are owned by insiders?
    133.8K BOLT shares are owned by insiders